Welcome

Specialties

Anatomical

Shoulder, Arm, Elbow, Hip, Knee, Foot and Ankle

Treatment

Arthritis, Deformity, Joint Replacement, Metabolic Bone Disease, Trauma/Fractures, Tumor/Oncology

More about Specialties »

My approach to treating patients

Dr. Casas is an orthopedic surgeon specializing in the management of malignant and benign bone and soft tissue tumors (sarcoma or bone cancer), cancer metastatic to bone, bone infections (osteomyelitis), and complex joint replacements. He is an expert in limb preserving surgery, which involves removal of a bone or soft tissue tumor or infection without amputation.

Dr. Casas and his associate, Dr. Gerhard Maale, employ a team approach in the treatment of all of their patients. All cases are reviewed in a weekly multidisciplinary conference involving orthopaedic surgeons, oncologists, radiologists, radiation oncologists, pathologists, infectious disease specialists, plastic surgeons, and internists. This ensures a state-of-the-art treatment plan tailored to each individual patient. Our comprehensive team approach has allowed many of our patients to lead disease-free lives.

Dr. Casas' research interests include the treatment of soft tissue sarcomas, metastatic bone disease, and benign bone tumors. He has co-authored scientific papers on the diagnosis and treatment of tumors and infections of the musculoskeletal system.

http://www.dfwsarcoma.com

More About Jorge Enrique Casas-Ganem, MD »

Contact Information

Dallas-Fort Worth Sarcoma Group 8230 Walnut Hill Lane Suite 514 Dallas, TX USA 75231 View map Phone (214) 691-9777 Fax (214) 691-1123

Other staff in my practice

Gerhard E. Maale, MD

This site has been viewed 2190 times.

This website is provided by the American Academy of Orthopaedic Surgeons as a service to its members. All materials on this Web site have been created, developed or assembled by the member physician, who is solely responsible for its content and any permissions necessary to properly place the materials on this website. The Academy does not review this information nor does it exercise editorial control over it.